全文获取类型
收费全文 | 820篇 |
免费 | 61篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 26篇 |
妇产科学 | 9篇 |
基础医学 | 122篇 |
口腔科学 | 13篇 |
临床医学 | 62篇 |
内科学 | 193篇 |
皮肤病学 | 34篇 |
神经病学 | 94篇 |
特种医学 | 17篇 |
外科学 | 88篇 |
综合类 | 14篇 |
预防医学 | 54篇 |
眼科学 | 5篇 |
药学 | 61篇 |
中国医学 | 3篇 |
肿瘤学 | 83篇 |
出版年
2024年 | 1篇 |
2023年 | 17篇 |
2022年 | 8篇 |
2021年 | 29篇 |
2020年 | 16篇 |
2019年 | 36篇 |
2018年 | 56篇 |
2017年 | 38篇 |
2016年 | 28篇 |
2015年 | 34篇 |
2014年 | 27篇 |
2013年 | 50篇 |
2012年 | 62篇 |
2011年 | 63篇 |
2010年 | 42篇 |
2009年 | 22篇 |
2008年 | 65篇 |
2007年 | 55篇 |
2006年 | 44篇 |
2005年 | 39篇 |
2004年 | 40篇 |
2003年 | 39篇 |
2002年 | 35篇 |
2001年 | 3篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 2篇 |
1992年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 5篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1981年 | 2篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有884条查询结果,搜索用时 15 毫秒
81.
82.
83.
Pesti Adrián Danics Krisztina Glasz Tibor Várkonyi Tibor Barbai Tamás Reszegi Andrea Kovalszky Ilona Vályi-Nagy István Dobi Deján Lotz Gábor Schaff Zsuzsa Kiss András 《Age (Dordrecht, Netherlands)》2023,45(2):1015-1031
GeroScience - The most severe alterations in Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) infection are seen in the lung. However,... 相似文献
84.
85.
86.
87.
Siebes RC Wijnroks L Ketelaar M van Schie PE Vermeer A Gorter JW 《Disability and rehabilitation》2007,29(5):373-380
PURPOSE. The objective was to validate the Dutch translation of the Canadian Giving Youth a Voice Questionnaire (GYV-20) for use in paediatric rehabilitation settings in The Netherlands. The GYV-20 consists of 20 items (assessing four domains) and was designed to evaluate the client-centredness of rehabilitation services from an adolescent perspective. METHOD. The construct validity, concurrent validity, and reliability of the Dutch GYV-20 were determined. Participants were 116 youngsters aged 11 - 21 years (Mean = 15.9; SD = 2.1) recruited through six paediatric rehabilitation settings in The Netherlands. RESULTS. Correlations between the GYV-20 scale scores were positive (r = 0.69 - 0.78). The GYV-20 showed adequate internal consistency, with Cronbach's alpha ranging from 0.76 - 0.81. The ICCs of test-retest reliability ranged from 0.82 - 0.92, which demonstrated good stability of the GYV-20. Dutch adolescents judged the GYV-20 as a valuable and useful tool to evaluate rehabilitation services in The Netherlands. CONCLUSIONS. The Dutch GYV-20 showed sufficient evidence of construct validity and good reliabilities. The Dutch GYV-20 offers users a useful measurement option for various research and clinical purposes. 相似文献
88.
Crespo M Pou L Esteban JI Falcó V Ribera E Lopez R Sauleda S Curran A Villar del Saz S Feijoo M Ocaña I Pahissa A 《Antiviral therapy》2007,12(8):1217-1223
BACKGROUND: Emerging data suggest that higher ribavirin (RBV) exposure could improve early hepatitis C virus (HCV) response. Furthermore, interindividual RBV bioavailability shows high variation, and dose-limiting haemolytic anaemia is a common adverse event. Therefore, it has been suggested that monitoring RBV serum levels could be used to drive dose modification and to optimize management of HCV-infected patients receiving combination treatment. METHODS: To assess the effect of RBV serum levels on HCV RNA clearance at week 4 and 12 of treatment, and to determine the correlation between RBV serum concentration and haemoglobin decrease, RBV trough levels were measured by HPLC in stored serum samples obtained from 94 HCV-HIV-coinfected patients at week 4 and 12 of treatment with peginterferon-alpha2b (1.5 microg/kg/weekly) pIus ribavirin (800-1,200 mg/day). RESULTS: The median RBV levels increased from 1.70 microg/ml at week 4 to 1.97 microg/ml at week 12 of treatment (P = 0.001) and were independently predicted by weight-adjusted dose of RBV and co-administration of tenofovir. Haemoglobin drop was higher among patients who received zidovudine and weakly correlated with RBV level. Although RBV concentration was lower in genotype 1 or 4 HCV-infected patients who cleared the virus at treatment week 4, the ability of this parameter to discriminate between responders and non-responders at treatment week 4 and 12 was poor. CONCLUSION: Intracellular RBV accumulation early in treatment might improve the kinetics of HCV response in difficult to treat patients. Although this hypothesis and the potential interaction between RBV and tenofovir warrant further research, our data do not support RBV serum monitoring as a tool to optimize treatment in HCV-HIV-coinfected patients. 相似文献
89.
Lara Maria Gómez García Adela Escudero Carmen Mestre Jose L. Fuster Soler Antonia Pascual Martínez Jose M. Vagace Valero María Vela Beatriz Ruz Alfonso Navarro Lucia Fernández Adrián Fernández Alejandra Leivas Joaquin Martínez-López Cristina Ferreras Raquel De Paz Miguel Blanquer Victor Galán Berta González Antonio Pérez-Martínez 《Clinical Lymphoma, Myeloma & Leukemia》2021,21(5):328-337.e1
BackgroundAcute myeloid leukemia (AML) accounts for approximately 20% of pediatric leukemia cases; 30% of these patients experience relapse. The antileukemia properties of natural killer (NK) cells and their safety profile have been reported in AML therapy. We proposed a phase 2, open, prospective, multicenter, nonrandomized clinical trial for the adoptive infusion of haploidentical K562-mb15-41BBL–activated and expanded NK (NKAE) cells as a consolidation strategy for children with favorable and intermediate risk AML in first complete remission after chemotherapy (NCT02763475).Patients and MethodsBefore the NKAE cell infusion, patients underwent a lymphodepleting regimen. After the NKAE cell infusion, patients were administered low doses (1 × 106/IU/m2) of subcutaneous interleukin-2. The primary study endpoint was AML relapse-free survival. We needed to include 35 patients to demonstrate a 50% reduction in relapses.ResultsSeven patients (median age, 7.4 years; range, 0.78-15.98 years) were administered 13 infusions of NKAE cells, with a median of 36.44 × 106 cells/kg (range, 6.92 × 106 to 193.2 × 106 cells/kg). We observed chimerism in 4 patients (median chimerism, 0.065%; range, 0.05-0.27%). After a median follow-up of 33 months, the disease of 6 patients (85.7%) remained in complete remission. The 3-year overall survival was 83.3% (95% confidence interval, 68.1-98.5), and the cumulative 3-year relapse rate was 28.6% (95% confidence interval, 11.5-45.7). The study was terminated early because of low patient recruitment.ConclusionThis study emphasizes the difficulties in recruiting patients for cell therapy trials, though NKAE cell infusion is safe and feasible. However, we cannot draw any conclusions regarding efficacy because of the small number of included patients and insufficient biological markers. 相似文献
90.
Sahiratmadja E Wieringa FT van Crevel R de Visser AW Adnan I Alisjahbana B Slagboom E Marzuki S Ottenhoff TH van de Vosse E Marx JJ 《The British journal of nutrition》2007,98(4):684-690
Fe-deficiency anaemia is the most common cause of anaemia in developing countries. In these settings, many chronic infections, including tuberculosis (TB), are highly prevalent. Fe is an essential nutrient for both host and mycobacteria that play a pivotal role in host immunity and mycobacterial growth. A case-control study was performed in a TB-endemic region in Jakarta, Indonesia, among 378 pulmonary TB patients and 436 healthy controls from the same neighbourhood with the same socio-economic status. In a number of these subjects the Fe status could be explored. The distribution of three polymorphisms in the natural resistance-associated macrophage protein gene (NRAMP1) including INT4, D543N and 3'UTR was examined for a possible association with susceptibility to TB. Anaemia (corrected for sex) was present in 63.2 % of active TB compared with 6.8 % of controls, with female patients more often affected. Anaemia was more pronounced in advanced TB as diagnosed by chest radiography. Lower Hb concentrations in TB patients were accompanied by lower plasma Fe concentrations, lower Fe-binding capacity and higher plasma ferritin. After successful TB therapy, Fe parameters improved towards control values and Hb levels normalised, even without Fe supplementation. NRAMP1 gene polymorphisms were not associated with TB susceptibility, TB severity or anaemia. In conclusion, most active TB patients had anaemia, which was probably due to inflammation and not to Fe deficiency since TB treatment without Fe supplementation was sufficient to restore Hb concentration. 相似文献